draft
Small Grants on Primary Immunodeficiency Diseases (R03)
Offered by National Institutes of Health (NIH)
Key Details
Deadline Sunday, 16 October 2016
Award Amount $100 000
Host Country United States
Additional Information
Comments The purpose of this FOA is to support small grants in primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models, including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for, primary immunodeficiency diseases. Typical grants propose pilot and feasibility studies, secondary analysis of existing data, small, self-contained research projects, development of research methods, or development of new research technology. New Investigators, who have not received independent NIH funding, and investigators who are new to PID research are especially encouraged to apply to this FOA. A budget for direct costs of up to $50,000 per year may be requested (i.e., a maximum of $100,000 over two years).
About the Funder
Record Information
Last Verified 19 February 2026 by asntech
Last Updated May 2020
Source legacy-import